Anthrax vaccine: a review

被引：20

作者：

Grabenstein, JD ^{[1
]}

机构：

[1] USA, Med Command, Falls Church, VA 22041 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2003年 / 23卷 / 04期

关键词：

D O I：

10.1016/S0889-8561(03)00093-6

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Anthrax is a zoonotic disease, primarily of ruminants, that is caused by Bacillus anthracis. The three most common forms of anthrax are cutaneous, inhalational, and gastrointestinal. Anthrax can be a deadly disease if treatment does not begin early in the course of infection. An effective vaccine has been available in the United States since 1970, although it was not used widely until 1998. Research is underway to change the current US-licensed vaccine's route of administration to intramuscular and to reduce the number of doses in the basic series.

引用

页码：713 / +

页数：19

共 115 条

[101] 3 FACTORS OF ANTHRAX TOXIN - THEIR IMMUNOGENICITY AND LACK OF DEMONSTRABLE ENZYMIC ACTIVITY [J].